In this study arachidonate-phospholipid remodeling was investigated in resting and proliferating human T lymphocytes. Lymphocytes induced to proliferate with either the mitogen concanavalin A or with anti-CD3 (OKT3) in combination with interleukin 2 (OKT3/IL-2) showed a greatly accelerated rate of [ 3 H]arachidonatephospholipid remodeling compared with resting lymphocytes or with lymphocytes stimulated with OKT3 or IL-2 alone. The concanavalin A-stimulated cells showed a 2-fold increase in the specific activity of CoAindependent transacylase compared with unstimulated cells, indicating that this enzyme is inducible. Stimulation with OKT3 resulted in greatly increased quantities of the group VI calcium-independent phospholipase A 2 but not of the quantity of group IV cytosolic phospholipase A 2 . However, group IV phospholipase A 2 became phosphorylated in OKT3-stimulated cells, as determined by decreased electrophoretic mobility. Incubation of cells with the group VI phospholipase A 2 inhibitor, bromoenol lactone, or the dual group IV/group VI phospholipase A 2 inhibitor, methyl arachidonyl fluorophosphonate, did not block arachidonate-phospholipid remodeling resting or proliferating T cells, suggesting that these phospholipases A 2 were not involved in arachidonate-phospholipid remodeling. The incubation of nonproliferating human lymphocytes with inhibitors of CoA-independent transacylase had little impact on cell survival. In contrast, OKT3/IL-2-stimulated T lymphocytes were very sensitive to apoptosis induced by CoA-independent transacylase inhibitors. Altogether these results indicate that increased arachidonate-phospholipid remodeling is associated with T cell proliferation and that CoA-independent transacylase may be a novel therapeutic target for proliferative disorders.
Much effort has been expended to understand the mechanisms by which inflammatory cells regulate the release of arachidonic acid (AA) 1 from cellular phospholipids and the subsequent synthesis of AA-derived inflammatory metabolites including the prostaglandins and leukotrienes. In addition to regulating the activation of phospholipase(s) A 2 (PLA 2 ), which catalyzes the release of AA from phospholipids, it has been shown that inflammatory cells also regulate the distribution of this polyunsaturated fatty acid in cellular phospholipids via an arachidonate-phospholipid (PL)-remodeling pathway (1-3) (Fig. 1 ). This remodeling pathway involves the sequential movement of arachidonate from 1-acyl-2-arachidonylglycerophosphocholine species to 1-alkyl-2-arachidonylglycerophosphocholine, 1-acyl-2-arachidonylglycerophosphoethanolamine, and 1-alk-1-enyl-2-arachidonylglycerophosphoethanolamine species. The arachidonate-PL remodeling pathway is distinct from other phospholipid-remodeling activities such as base exchange (4) or phosphatidylethanolamine N-methyltransferasedriven remodeling (5) since the CoA-independent transacylase (CoA-IT)-catalyzed step is specific for long chain polyunsaturated fatty acids like arachidonic acid; phospholipids containing saturated, monounsaturated, or even di-unsaturated fatty acids like linoleic acid in the sn-2 position of the glycerol moiety do not show this characteristic remodeling pattern (6) and are not utilized as substrates by CoA-IT (7, 8) .
Arachidonate-phospholipid remodeling is largely characterized by the CoA-IT-driven transfer of arachidonate between phospholipid species and a PLA 2 catalyzed release of free arachidonic acid (1, 7, 9, 10) . Although the calcium-independent group VI PLA 2 (iPLA 2 ) has been suggested to be associated with arachidonate-PL remodeling (11) , the PLA 2 isotype associated with this pathway has not been definitively identified.
The rate of arachidonate-PL remodeling is transiently enhanced when leukocytes like neutrophils or mast cells are stimulated with agonists (12, 13) . This increased flux of arachidonate between phospholipid species has been hypothesized to be involved in regulating the release of AA by moving arachidonate into phospholipid pools that are accessible to arachido-* These studies were supported by a grant from the Medical Research Council of Canada and were presented in part at the 6th International Conference on Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation-related Diseases, Boston, MA, September 12-15, 1999 . The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Recipient of a Scholarship from Le Fonds de la Recherche en Santé du Québec. To whom correspondence should be addressed: Pilot Therapeutics Inc., 101 N. Chestnut St., Winston-Salem, NC 27103. Tel.: 336-725-2222; Fax: 336-725-2221; E-mail: marc.surette@crchul. ulaval.ca. nate-specific PLA 2 (s). In an effort to uncover molecules that selectively inhibit the release of arachidonic acid, structurally different classes of compounds were discovered that inhibit CoA-IT (14, 15) . These compounds were shown to be effective inhibitors of arachidonic acid release and, consequently, of leukotriene synthesis in activated leukocytes (16) . It was recently observed that several cell lines including human promyelocytic HL-60 cells, monocyte-like THP-1 cells, macrophagelike P388D 1 cells, and the breast cancer cell lines MCF-7 and MDA-MB-231 remodel AA very rapidly through the arachidonate-PL pathway (17) (18) (19) . When these neoplastic cell lines are incubated with CoA-IT inhibitors, not only is arachidonate-PL remodeling effectively inhibited, but the cells readily undergo cell cycle arrest and apoptotic cell death (18, 20, 21) . Importantly, isomers of CoA-IT inhibitors, which possess no inhibitory activity against CoA-IT, do not induce apoptosis in these cells (20) . AA itself seems to play a central role in CoA-IT inhibitor-induced apoptosis since arachidonate-depleted HL-60 cells are much less susceptible to inhibitor-induced apoptosis than non-depleted cells (22) . Since arachidonate is rapidly remodeled in these cell lines, CoA-IT inhibition leads to a marked accumulation of free AA, which may impart an anti-proliferative or pro-apoptotic signal through ceramide generation or after its transformation to oxygenated derivatives (18, 22) . A similar mechanism of cell death triggered by an accumulation of free AA has been proposed for cells treated with cyclooxygenase inhibitors (23) .
The susceptibility of these proliferating neoplastic cell lines to apoptosis induced by CoA-IT inhibitors may be related to their rapid rate of arachidonate-PL remodeling. However, it is not known if enhanced remodeling activity is a characteristic of proliferating cells or whether accelerated remodeling necessarily renders cells sensitive to apoptosis after CoA-IT inhibition. In the present study, human peripheral blood T lymphocytes were used to determine whether flux through the arachidonate-PL-remodeling pathway is enhanced when non-neoplastic cells are induced to proliferate. Our results show that the rate of arachidonate-PL remodeling is greatly increased when human T cells move out of G 0 and begin to divide. This enhanced rate of arachidonate-PL remodeling was associated with an induction of CoA-IT activity but did not depend on iPLA 2 or group IV cytosolic PLA 2 (cPLA 2 ) activity. Importantly, proliferating but not resting T cells were very sensitive to cell death induced by CoA-IT inhibitors. These results suggest that accelerated arachidonate-PL remodeling is a characteristic of proliferating cells and that CoA-IT may be a novel therapeutic target for proliferative disorders. [5, 6, 8, 9, 11, 12, 14, Lymphocyte Preparation and Culture-Human lymphocytes were isolated from the heparinized blood of healthy donors as previously described (24) . Briefly, lymphocytes (Ͼ85% purity) were prepared by sequential centrifugation on Ficoll and Percoll gradients. In experiments where Ͼ99% pure lymphocytes were utilized, cells were further enriched by cell sorting after gating on lymphocytes on the basis of forward/side scatter (Epics Elite ESP, Coulter, Miami, FL). After their isolation, cells (1 ϫ 10 6 cells/ml) were incubated for the indicated times at 37°C in a 5% CO 2 atmosphere with or without 10 g/ml ConA or 1 g/ml OKT3. In cells incubated with OKT3, 20 units/ml IL-2 were added 24 h after the addition of OKT3 unless indicated otherwise.
MATERIALS AND METHODS

Reagents-The
Pulse 7 cells) were added to cell suspensions that were then incubated for 30 min at 37°C in a shaking water bath. The cells were then washed twice with 10% fetal bovine serum in RPMI and resuspended in their original incubation medium. In some experiments, BEL, MAFP, SB 203347, or LY311727 were added to the cells immediately after pulse-labeling.
Extraction and Analysis of Lipids-Incubations were terminated by washing cells once by centrifugation in cold Hanks' balanced salt solution followed by extraction of cellular lipids with organic solvents (25) . The phospholipid classes of the extracts were separated by HPLC using a silica column with a hexane, 2-propanol, ethanol, 25 mM phosphate buffer (pH 7.4), acetic acid (490:367:100:30:0.6, v/v/v/v/v) mobile phase. After 5 min, the composition of phosphate buffer was increased from 3 to 5%, the acetic acid composition was decreased from 0.06 to 0.02% over a 5-min period, and these concentrations were maintained for the remainder of the run (26) . Fractions containing neutral lipids, PE, PI/PS, and PC were collected. The extracts were dried under N 2 , and the [ 3 H]arachidonate content of each fraction was measured by liquid scintillation counting (Beckman Instruments LS 5000 CE).
The phospholipid subclass analysis was performed as previously described (17) . The PE and PC fractions isolated by HPLC were dried under a nitrogen stream and vortexed in 1 ml of 100 mM Tris buffer (pH 7.4). Phospholipase C, 40 and 20 units, was added to the PE and PC fractions, respectively, followed by 2 ml of ethyl ether, and the solutions were incubated for 6 h at 37°C in a shaking water bath. The resulting diglycerides were extracted with 2 ml of hexane and then again with 2 ml of hexane/ether (1:1, v/v). The pooled extracts were dried under a stream of nitrogen, and acetylated derivatives were prepared by incubating overnight in pyridine/acetic anhydride (1:5, v/v) at 37°C in a shaking water bath. The solution was dried under N 2 and extracted twice with ether/hexane (1:1, v/v). The extract was washed once with 1 ml of water, and the subclasses were separated by TLC using a benzene/ hexane/ether (50:45:4, v/v/v) mobile phase. The areas containing 1-acyl, 1-alkyl, and 1-alk-1-enyl-linked lipids were identified by co-migration of standards, which were visualized with iodine. The corresponding areas were scraped, and associated radioactivity was determined by liquid scintillation counting.
CoA-IT Activity Assay-CoA-IT activity was measured in lymphocyte membrane preparations. Cells were first sonicated in 80 mM KCl, 10 mM Hepes, 1 mM EGTA, 1 mM EDTA (pH 7.4), 5 g/ml leupeptin, 10 mM NaF, and 0.2 mM NaVO 3 . The sonicate was then centrifuged at 8000 ϫ g for 15 min (4°C), and the resulting supernatant was centrifuged at 100,000 ϫ g for 45 min (4°C). The resulting pellet was resuspended in PBS buffer (pH 7.4) containing EGTA (1 mM). The CoA-IT activity assay was performed as described previously (27) in a total volume of 100 l containing 3 g of membrane protein. The reaction was initiated by the addition of 1-O- [ 3 H]alkyl(octadecyl)-2-lyso-PC (0.5 Ci/assay) diluted in assay buffer containing 250 g/ml bovine serum albumin and a varied (0 to 1 M) final concentration of unlabeled 1-O-alkyl(octadecyl)-2-lyso-PC. The reaction was allowed to proceed for 10 min at 37°C and was stopped with 300 l of chloroform/methanol (1:2 v/v). The lipids were then extracted (25) , and lyso-PC and PC standards were added as carrier lipids. Lipids were separated by TLC using chloroform/methanol/acetic acid/water (50:25:8:4 v/v/v/v). For kinetic analysis experiments, the assay was configured so that less than 5% of the substrate was converted to product in order to ensure that zero order kinetics could be applied.
Determination of Apoptosis-After the indicated times of cell culture, apoptosis was determined using the annexin V-PI apoptosis detection kit according to the manufacturer's instructions (R & D Systems, Minneapolis, MN) and by poly(ADP-ribose) polymerase (PARP) cleavage, detected by immunoblotting using the monoclonal antibody C2-10 directed against PARP (28) (a generous gift from Dr Guy Poirier, Center Hospitalier de l'Université Laval, Québec, Canada).
Immunoblot Analysis of iPLA 2 and cPLA 2 -Lymphocyte cytosolic proteins (50 g) were separated by SDS-polyacrylamide gel electrophoresis (29) and transferred to a nitrocellulose membrane that was blocked 30 min at room temperature with 5% milk protein in TBSTween (25 mM Tris-HCl, 190 mM NaCl (pH 7.6), and 0.15% Tween 20). The membrane was then washed in TBS-Tween and incubated with polyclonal antibody to iPLA 2 (Cayman Chemical Co, Ann Arbor, MI) (1:500 dilution v/v) or with a 1:500 dilution (v/v) of the polyclonal antibody to cPLA 2 , MF 142 (a generous gift from Dr. Philip Weech of Merck Frosst, Canada), in 1% milk protein in TBS-Tween for 1 h at room temperature. The nitrocellulose membranes were then washed 5 times for 5 min each in TBS-Tween and incubated for 1 h at room temperature with a horseradish peroxidase-linked goat anti-rabbit IgG (1:10 000) (Bio-Can Scientific, Mississauga, Ontario, Canada) diluted in TBS-Tween containing 1% milk protein. After having washed the membrane 5 times with TBS-Tween for 5 min each, the antibody complex was visualized by enhanced chemiluminescence Plus (MandelPerkinElmer Life Sciences).
[ 3 H]Thymidine Incorporation-Lymphocytes (1 ϫ 10 6 cells/ml) incubated for the various incubation times were exposed to [ 3 H]thymidine (1 Ci/well containing 200,000 cells) for 18 h. The incorporated radioactivity was collected on a glass fiber filter (Printed Filtermat A, Wallac Oy, Turku, Finland) with a cell harvester (Tomtec, Orange, Conn), and the radioactivity was quantified with a liquid scintillation counter 1450 Microbeta (Wallac Oy, Turku, Finland).
Protein Determination-Protein content was determined according to a modification of the Lowry method as previously described (30) .
RESULTS
Lymphocyte Proliferation and Arachidonate-Phospholipid
Remodeling-Rapidly proliferating transformed cell lines exhibit very rapid arachidonate-PL remodeling (17) (18) (19) . These observations suggest that either cell transformation induces an increased flux of arachidonate through this remodeling pathway or that this pathway is accelerated when cells enter the cell cycle and proliferate. Therefore, a first set of experiments investigated whether the induction of cell proliferation results in an enhanced arachidonate-PL remodeling in nontransformed cells. Human lymphocytes were isolated from the peripheral blood of healthy volunteers and incubated without the addition of a stimulus or stimulated with either the T cell mitogen ConA, IL-2, the anti-CD3 antibody OKT3, or with OKT3 followed 24 h later with IL-2 (OKT3/IL-2). When freshly isolated lymphocytes were pulse-labeled with [ 3 H]AA and allowed to incubate for up to 24 h, a slow but measurable redistribution of the radiolabel from PC to PE species was observed ( Fig. 2A) . This redistribution of arachidonate from PC species to PE species is a hallmark of arachidonate-phospholipid remodeling. A similarly slow but measurable rate of [ 3 H]arachidonate redistribution between phospholipid species was observed when unstimulated cells were pulse-labeled after 1, 2, 3, or 4 days of incubation (data not shown). When freshly isolated, [ 3 H]arachidonate-pulse-labeled cells were stimulated with ConA for 24 h; a similarly slow redistribution of the radiolabel from PC to PE species was also observed. As expected, during this initial 24-h period little induction of cell proliferation was observed in ConA-stimulated cells as determined by [ Arachidonate-PL remodeling in resting and stimulated lymphocytes. Freshly isolated unstimulated lymphocytes (A) or lymphocytes incubated for 3 days in culture medium with 10 g/ml ConA (B), 1 g/ml anti-CD3 and 20 units/ml IL-2 (C), 1 g/ml anti-CD3 (D), or 20U/ml IL-2 (E) were pulse-labeled with [ 3 H]AA as described under "Materials and Methods." At the indicated times, labeled cells were removed from the incubation culture medium, lipids were extracted and separated by HPLC, and the radioactivity associated with each phospholipid class, namely PE (‚), PI/PS (E), and PC (Ⅺ), was determined by liquid scintillation counting. These results are the mean Ϯ S.E. of four independent experiments. counting (data not shown). These cells were determined to be Ͼ99% pure T cells after CD3 staining and fluorescence-activated cell sorter analysis (data not shown). When these 3 day-stimulated T cells were then pulse-labeled with [ 3 H]AA and allowed to incubate further, a very rapid redistribution of [ 3 H]arachidonate from PC to PE species was observed (Fig. 2, B  and C) . Stimulation of T cells with either OKT3 or IL-2 alone did not induce the degree of cell proliferation (Fig. 3) or increased rate of remodeling (Fig. 2, D and E (Table I) . Altogether, these results indicate that a very rapid rate of arachidonate-PL remodeling is associated with the proliferation of peripheral blood T cells.
CoA-IT Activity-The remodeling of arachidonate between phospholipid species requires several enzymatic activities. The step that is unique to this pathway is that which is catalyzed by CoA-IT. This enzyme has not yet been isolated; however, its activity has been characterized and can be assayed in broken cell preparations (27) . To determine whether the enhanced remodeling measured in proliferating T cells may be associated with an increase in CoA-IT activity, 100,000 ϫ g particulate fractions were prepared from both unstimulated and ConAstimulated lymphocytes, and CoA-IT activity was assayed. As can be seen in Fig. 4 , 100,000 ϫ g fractions from stimulated cells consistently showed an ϳ2-fold increase in CoA-IT activity compared with unstimulated cells, indicating that the enhanced flux of arachidonate through the remodeling pathway observed in stimulated cells was associated with an induction of CoA-IT activity.
Phospholipase(s) A 2 in Lymphocytes-Another key step associated with this remodeling pathway is that catalyzed by a PLA 2 (Fig. 1) . However, the PLA 2 isotype involved in arachidonate-PL remodeling has not been definitively identified. It was previously suggested that iPLA 2 may be involved in arachidonate-PL remodeling because the treatment of P388D 1 cells with the iPLA 2 inhibitor, BEL, inhibits the incorporation of AA into cellular phospholipids (11) . However, since arachidonate-PL remodeling is specific to highly unsaturated fatty acids like AA (6, 10) , an arachidonate-specific PLA 2 may also be involved in generating the lysophospholipid species used as acceptor phospholipids in the CoA-IT-catalyzed reaction. For that reason, the arachidonate-specific group IV cPLA 2 could be a candidate for this step in the pathway.
Therefore, the expression of these two PLA 2 isotypes was determined in resting and stimulated T cells. Fig. 5 shows that although resting T cells expressed cPLA 2 , very little if any iPLA 2 was detected by immunoblot analysis. However, when T cells were stimulated with OKT3/IL-2, iPLA 2 protein levels were greatly increased. Although co-stimulation with anti-CD3 and IL-2 was required for enhanced arachidonate-PL remodeling, CD3 stimulation alone was sufficient to induce iPLA 2 expression. Although no apparent increase in the protein content of cPLA 2 was measured in stimulated cells, the cPLA 2 from CD3-stimulated T cells migrated more slowly on polyacrylamide gels than that from unstimulated cells. Identical results were obtained in lymphocytes purified by cell sorting and stimulated with ConA (data not shown). This gel shift of cPLA 2 has been shown to be due to the phosphorylation of the protein on serine residue 505 and is associated with the activation of the enzyme (31). As with iPLA 2 expression, CD3 stimulation alone in the absence of added IL-2 was sufficient to induce cPLA 2 phosphorylation in human T cells.
PLA 2 Inhibition Studies-The up-regulation of iPLA 2 and phosphorylation of cPLA 2 after cell stimulation suggested that these PLA 2 isotypes may be associated with the enhanced arachidonate-PL remodeling described above. Therefore, the impact of different PLA 2 inhibitors on the remodeling process was evaluated. T cells were stimulated with ConA or OKT3/ IL-2 for 72 h and then pulse-labeled with [ 3 H]AA and incubated in the presence of the irreversible iPLA 2 inhibitor BEL (32) or the irreversible dual iPLA 2 -cPLA 2 inhibitor MAFP (33, 34) . As can be seen in Table II , the incubation of cells for 5 h with 12.5 M BEL, a concentration shown to inhibit AA incorporation in P388D 1 cells (11), had no effect on the sequential movement of [ 3 H]arachidonate between phospholipid species even though the IC 50 of this irreversible iPLA 2 inhibitor is 60 nM (32) . More prolonged incubation (15 h) of either resting or stimulated T cells with 12.5 M BEL was cytotoxic to these cells. Similarly, higher concentrations of BEL (25 M) was also cytotoxic to both resting and stimulated cells, inducing rapid and complete cell death within 5 h (data not shown). BEL is also known to inhibit phosphatidate phosphohydrolase (35, 36) . When cells were incubated with another phosphatidate phosphohydrolase inhibitor, propranolol (100 M), cell death was also readily induced, as determined by annexin V-PI staining and PARP cleavage (data not shown), suggesting that this enzyme may be required for T cell survival.
When stimulated cells were incubated with the irreversible dual iPLA 2 /cPLA 2 inhibitor MAFP, no effect on arachidonate-PL remodeling was observed when concentrations as high as 50 M were added to the incubation medium for up to 15 h (Table II) . MAFP inhibits both iPLA 2 and cPLA 2 in the high nM range (33, 37, 38) , and in whole cells MAFP has been shown to inhibit the release of AA from stimulated human neutrophils and platelets with an IC 50 in the range of 10 nM-1 M (38 -40). These results indicate that although mitogen stimulation of human T cells results in an up-regulation of the group VI iPLA 2 and the phosphorylation of the arachidonate-specific group IV
FIG. 3. Effects of stimuli on [
3 H]thymidine incorporation. Lymphocytes (1 ϫ 10 6 cells/ml) were incubated at 37°C without the addition of stimuli (Unstimulated), with 1 g/ml anti-CD3 (OKT3), 20 units/ml IL-2, or with both stimuli (OKT3 ϩIL-2) for 3 days as described under "Materials and Methods." [ 3 H]thymidine (1 Ci/well) was added for 18 h, and the incorporation of radioactivity into cells was measured by liquid scintillation counting. These results are the average of three independent experiments, each performed in triplicate. cPLA 2 , another as yet undetermined PLA 2 isotype that is not inhibited by MAFP or BEL may be involved in arachidonate-PL remodeling in human T cells.
Inhibitors of CoA-IT Induce Apoptosis in Proliferating but Not Resting T Cells-The sensitivity of transformed cell lines to
CoA-IT inhibitors has been attributed to the very rapid rate of arachidonate-PL remodeling in these cells (22) . We hypothesized that cells that slowly remodel arachidonate may be less sensitive to CoA-IT inhibitor-induced apoptosis but that an increased rate of arachidonate-PL remodeling would render cells sensitive to CoA-IT inhibition. The observation that proliferating T cells exhibited greatly accelerated arachidonate-PL remodeling compared with resting cells provided an excellent model to test this hypothesis. When resting, nonstimulated lymphocytes were incubated with CoA-IT inhibitors; no induction of apoptosis was measured as assessed by PARP cleavage (Fig. 6) . However, T cells stimulated with OKT3/IL-2 were very sensitive to the induction of cell death by the CoA-IT inhibitor, SK&F 98625, resulting in a complete cleavage of PARP in these cells (Fig. 6) . Cleavage of PARP is an indication of caspase 3-like activity since PARP is characteristically cleaved at a DEVD site, resulting in the disappearance of the 116-kDa parent protein and the specific appearance of the 89-kDa cleavage product. Interestingly, 10 times more protein from nonstimulated cells than from stimulated cells was loaded onto the gels, indicating that PARP protein levels were increased in stimulated cells.
The dose response to CoA-IT inhibitors was assessed using the annexin V-PI-staining method, which measures the loss of membrane asymetry associated with apoptosis and which allows a more quantitative assessment of cell death. As can be seen in Fig. 7A , resting cells or cells stimulated with IL-2 alone underwent little apoptosis when incubated with up to 30 M of the CoA-IT inhibitor SK&F 98625. This concentration was previously shown to be very effective in inducing apoptosis in HL-60 cells (20) . On the other hand, T cells co-stimulated with OKT3/IL-2 that exhibit rapid arachidonate-PL remodeling were much more sensitive to CoA-IT inhibitors and underwent apoptosis in a dose-dependent manner when incubated with SK&F 98625. Interestingly, cells stimulated with OKT3 showed an intermediate sensitivity to CoA-IT inhibition, which corresponded to the sub-optimal induction of cell proliferation and arachidonate-PL remodeling measured in these cells. This suggests that the sensitivity of T cells to apoptosis induced by CoA-IT inhibitors is linked to their rate of arachidonate-PL remodeling.
The pattern of annexin V and PI staining in resting and OKT3/IL-2-stimulated cells is shown in Fig. 7B . The annexin V staining and PI uptake obtained after the incubation of these cells with CoA-IT inhibitors shows a typical apoptotic pattern with the progression of double negative cells toward double positive cells with an annexin V-positive/PI-negative intermediate. Although this sensitive method measured a small increase in annexin V-positive cells when resting cells were incubated with CoA-IT inhibitors, both OKT3/IL-2 and ConA (not shown)-stimulated T cells were much more responsive to the induction of apoptosis after incubation with SK&F 98625 (Fig.  7B) or the structurally distinct CoA-IT inhibitor, SK&F 45905 (data not shown). Overall, these results are consistent with the 6 cells/ml) were incubated at 37°C without the addition of stimuli (Unstimulated) with 1 g/ml anti-CD3 (OKT3), 20 units/ml IL-2, or with both stimuli (OKT3 ϩ IL-2) for 3 days as described under "Materials and Methods." Cytosolic proteins (50 g) were separated by SDS-polyacrylamide gel electrophoresis, and cPLA 2 and iPLA 2 were revealed by immunoblot analysis. The results are representative of four separate experiments. 
DISCUSSION
Previous studies show that arachidonate-PL remodeling occurs at a very rapid rate in neoplastic cell lines (19, 21, 22) and that these cells undergo cell cycle arrest and apoptosis when treated with inhibitors of CoA-IT (18, 20, 21) . The hypothesis in the present study was that arachidonate-PL remodeling would be accelerated when non-neoplastic cells are induced to proliferate and that such cells would be rendered sensitive to the induction of apoptosis by CoA-IT inhibitors. The results presented herein support this hypothesis by showing that mitogen-stimulated human T cells exhibit very rapid arachidonate-PL remodeling once they begin to proliferate compared with resting cells. Importantly, these proliferating T cells also become sensitive to the action of CoA-IT inhibitors, which effectively induce apoptotic cell death in stimulated but not resting human T cells.
Human peripheral blood T cells were an ideal model in which to compare arachidonate-PL remodeling in resting and proliferating cells since they readily and reproducibly enter the cell cycle upon appropriate stimulation. The results presented here clearly indicate that when human T cells are stimulated with a mitogen or with activating anti-CD3 antibodies in the presence of IL-2, the induction of cell proliferation is accompanied by an acceleration of the arachidonate-phospholipid-remodeling pathway. In addition to supporting the premise that an increased rate of remodeling is a characteristic of proliferating cells, T cells also provided a good model to study the regulation of arachidonate-PL remodeling. This pathway is characterized by the CoA-IT-driven transfer of arachidonate between phospholipid species but not that of shorter chain or more saturated fatty acids. This membrane-bound enzyme has not yet been isolated due to the difficulties in retaining enzymatic activity when particulate cell fractions are treated with detergents. Nonetheless, in mitogen-stimulated cells, the specific activity of CoA-IT was doubled compared with that of resting lymphocytes, indicating that this enzymatic activity is inducible. However, the flux of arachidonate between phospholipid species was increased severalfold since stimulated cells pulse-labeled with [ 3 H]AA approached isotopic equilibrium within 5 h, whereas resting cells had not yet attained isotopic equilibrium after a 48-h incubation (data not shown). This suggests that other potential sites of regulation of this pathway may also be operative.
Phospholipase(s) A 2 is usually involved in the regulation of cellular arachidonic acid release in acutely stimulated cells and may, therefore, also play a role in the regulation of arachidonate-PL remodeling. It has been suggested that the calciumindependent group VI iPLA 2 may be the PLA 2 isotype involved in the release of AA in the arachidonate-PL-remodeling pathway (11) . The observation in the present study that this protein is up-regulated in CD3-stimulated T cells is consistent with its potential role in arachidonate-PL remodeling. However, the treatment of cells with the iPLA 2 inhibitor BEL was without effect on the redistribution of radiolabeled arachidonate in pulse-labeled cells. This lack of effect of iPLA 2 inhibition on arachidonate remodeling was confirmed in cells incubated with the dual iPLA 2 /cPLA 2 inhibitor, MAFP, which did not alter the redistribution of radiolabeled AA in pulse-labeled cells at concentrations as high as 50 M. Therefore, although the group VI iPLA 2 is up-regulated, two different iPLA 2 inhibitors used at concentrations that have been shown to inhibit AA release and iPLA 2 activity in whole cells failed to affect the remodeling pathway. This result is in accord with a recent report in pancreatic beta cells where BEL had no effect on the movement of arachidonate from PC to PE species (36) .
These inhibitor studies also suggest that the 85-kDa group IV cPLA 2 is not involved in arachidonate-phospholipid remodeling. The arachidonate-specific cPLA 2 was an obvious candidate to be involved in arachidonate-PL remodeling since it is the only PLA 2 isotype described to date that shows high specificity for 2-arachidonyl-phospholipids (41, 42) . The lack of effect of MAFP on remodeling is consistent with an earlier report that showed that cPLA 2 is not involved in the CoA-IT-dependent generation of platelet-activating factor in ionophore-stimulated neutrophils (43) . Interestingly, in the present study cPLA 2 was activated in stimulated T cells since the characteristic gel shift that is associated with its phosphorylation and activation was observed. It is possible that cPLA 2 activation plays a role in the previously described arachidonic acid release coupled to 5-lipoxygenase product synthesis in CD28-stimulated T cells (44) . There is some evidence that secretory PLA 2 (s) like the group V or group IIa sPLA 2 may in some cases have specificity for 2-arachidonyl-phospholipids or even a preference for phosphatidylethanolamine species over phosphatidylcholine species in certain conditions (45) . However, no evidence for an increase in PLA 2 activity in the incubation medium of stimulated cells could be demonstrated, and two separate sPLA 2 inhibitors, SB 203347 and LY 311727, had no effect on remodeling (data not shown). Overall, these results cast doubt on the role of the known PLA 2 isotypes most likely to be involved in arachidonate-PL remodeling and suggest that another, perhaps as yet unidentified, PLA 2 may be involved in the arachidonate-PL-remodeling pathway.
Previous studies show that neoplastic cells lines undergo apoptosis when incubated with CoA-IT inhibitors (18, 20, 21) . That these cell lines remodel arachidonate very rapidly suggested that their sensitivity to CoA-IT inhibitors may be related to the flux of arachidonate through this pathway. Having established in the present study that the arachidonate-PLremodeling pathway was greatly accelerated after the induction of T cell proliferation, the sensitivity to CoA-IT inhibitors could be compared in cells that rapidly or slowly remodel arachidonate. The sensitivity of T cells to apoptosis induced by CoA-IT inhibition was very much dependent on whether the cells were rapidly undergoing arachidonate-PL remodeling. Unstimulated T cells were much less sensitive to the induction of apoptosis after CoA-IT inhibition compared with stimulated proliferating T cells. In fact, no cleavage of PARP was detected when resting cells were incubated with CoA-IT inhibitors. Consistent with the link between accelerated arachidonate-PL remodeling and sensitivity to CoA-IT inhibition, T cells that were stimulated for 24 h but that had not yet begun to proliferate or FIG. 6 . Poly(ADP-ribose) polymerase cleavage in stimulated T cells incubated with the CoA-IT inhibitor SK&F 98625. Human lymphocytes were incubated for 3 days without the addition of stimuli or were stimulated for 3 days with a combination of 1 g/ml OKT3 and 20 units/ml IL-2 as described under "Materials and Methods." The CoA-IT inhibitor SK&F 98625 (25 M) or its diluent (Me 2 SO) were then added to the incubation medium, and the incubations were continued for another 8 h. Cell proteins were then prepared and separated by SDS-polyacrylamide gel electrophoresis, and intact PARP as well as its 89-kDa cleavage product were revealed by immunoblot analysis. Gels were loaded with 10 times more protein from nonstimulated cells than from cells stimulated with OKT3/IL-2. The results are representative of five separate experiments.
accelerate the remodeling pathway were also much less sensitive to CoA-IT inhibitors than proliferating T cells. The sensitivity of HL-60 cells, which rapidly remodel arachidonate, to CoA-IT inhibition was suggested to be due to the rapid accumulation of the pathway intermediate free AA and its activation of a sphingomyelinase leading to ceramide generation (22) . A similar cell death mechanism where the cell's inability to control free AA levels leads to increased ceramide concentration has been suggested to occur after cPLA 2 activation in TNF-sensitive cells (46, 47) and in cells treated with cyclooxygenase inhibitors (23) . In resting cells where arachidonate-PL remodeling proceeds slowly, pathway intermediates like free AA would accumulate to a lesser extent after CoA-IT inhibition, likely allowing the cell to cope with any released free AA via reacylation into phospholipids or triglycerides.
The present study indicates that rapid arachidonate-PL remodeling is a likely characteristic of proliferating cells and responsible for their susceptibility to cell death resulting from CoA-IT inhibition. These cells may require a rapid and specific organization of arachidonyl-phospholipids to ensure that this polyunsaturated fatty acid is properly distributed in the membrane phospholipids of newly synthesized cell structures. Indeed, arachidonic acid metabolites are involved in the regulation of numerous cellular processes, which would explain why cells have developed a specific pathway to control its distribution in phospholipid species. Importantly, the observation that the induction of this remodeling pathway is associated with cell proliferation and renders cells susceptible to apoptotic cell death after the inhibition of CoA-IT supports the concept that CoA-IT may be a specific therapeutic target for proliferative disorders including lymphoproliferation associated with autoimmune diseases or graft rejection. FIG. 7 . The induction of apoptosis in resting and stimulated T cells by the CoA-IT inhibitor SK&F 98625. A, human lymphocytes were incubated for 3 days without the addition of stimuli (Ⅺ) or were stimulated with 1 g/ml anti-CD3 (OKT3) (E), 20 units/ml IL-2 (f), or with a combination of 1 g/ml OKT3 and 20 units/ml IL-2 (q) as described under "Materials and Methods." The indicated concentrations of the CoA-IT inhibitor SK&F 98625 were then added to the incubation medium, and the cells were incubated for an additional 15 h. Cells were then evaluated for apoptosis by annexin V staining and PI uptake as described under "Materials and Methods." Cells that were both annexin V-and PI-negative (lower left quadrant in B) were considered as living cells. These results are the mean Ϯ S.E. of four independent experiments. B, human lymphocytes were incubated for 3 days without the addition of stimuli or were stimulated with a combination of 1 g/ml OKT3 and 20 units/ml IL-2 as described under "Materials and Methods." The CoA-IT inhibitor SK&F 98625 (25 M) or its diluent (Me 2 SO) was added to the incubation medium, and the cells were incubated for additional 8 h. The cells were then evaluated for apoptosis by annexin V staining and PI uptake as described under "Materials and Methods." The numbers represent the percentage of cells in each quadrant. The results are from one experiment and are representative of five separate experiments.
